Page 3 - Peter Denardo News Today

Operator: Good morning, and welcome to the Renalytix Conference Call to Review Fourth Quarter and Full-Year Fiscal 2023 Financial Results. At this time, all participants are in a listen-only mode.

LONDON and SALT LAKE CITY, Sept. 28, 2023 -- Renalytix plc , an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive...

LONDON and SALT LAKE CITY, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) will report its fourth quarter and full year...

LONDON and SALT LAKE CITY, Sept. 25, 2023 -- Renalytix plc will report its fourth quarter and full year fiscal 2023 financial results on Thursday, September 28, 2023, before market open. The...

SOUTH SAN FRANCISCO, Calif., July 25, 2023 -- Standard BioTools Inc. , driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – today announced that it will...

Issue of Shares LONDON and SALT LAKE CITY - July 17, 2023 - Renalytix plc , announces the repayment of $1.06 million of the Companys convertible bond, further details of which...

Directorate Change Renalytix Appoints Financial Executive Catherine Coste to its Board of Directors LONDON and SALT LAKE CITY - July 3, 2023 - Renalytix plc ,...

Operator: Good morning, and welcome to the Renalytix Conference Call to Review Third Quarter Fiscal Year 2023 Financial Results. At this time, all participants are in a listen-only mode.

LONDON and SALT LAKE CITY, June 05, 2023 -- Renalytix plc will report its third quarter fiscal year 2023 financial results on Friday, June 9, 2023, before market open. The Company will host a... | June 5, 2023

Industry veteran Jeffrey Black brings 30 years of financial and operating leadership experience Vikram Jog to become Special Advisor for transition period...